Skip to main content

Table 3 Hazard ratio for risk factors using variables selected by the LASSO method

From: Risk assessment and prediction of TD incidence in psychiatric patients taking concomitant antipsychotics: a retrospective data analysis

Patient characteristics

Univariate Cox analyses

Variables selected by the LASSO method

Hazard Ratio

95% CI

P value

Hazard ratio

95% CI

P value

Age (years)

1.04

(1.03, 1.04)

< 0.001

1.04

(1.03, 1.04)

< 0.001

Square root of age

1.72

(1.60, 1.84)

< 0.001

   

Age less than 65 indicator

0.33

(0.27, 0.41)

< 0.001

   

Index Diagnosis vs. Bipolar Disorder

 Depressive Disorder

0.95

(0.78, 1.14)

0.57

1.02

(0.79, 1.32)

0.88

 Schizophrenia

1.96

(1.67, 2.29)

< 0.001

1.99

(1.57, 2.53)

< 0.001

Generation of Index AP vs. First generation

 Multiple

0.88

(0.58, 1.33)

0.54

0.80

(0.52, 1.21)

0.29

 Second generation

0.72

(0.59, 0.87)

< 0.001

0.85

(0.70, 1.03)

0.09

Dose (continuous effect for dose≤100 mg/day of chlorpromazine)

1.91

(1.38, 2.66)

< 0.001

1.65

(1.17, 2.31)

< 0.01

Dose (continuous effect for dose> 100 mg/day of chlorpromazine)

1.05

(1.02, 1.08)

< 0.01

   

CCI

1.06

(1.00, 1.12)

< 0.05

   

Depressive disorders

0.78

(0.68, 0.89)

< 0.001

   

Bipolar and related disorders

0.84

(0.72, 0.97)

< 0.05

1.39

(1.11, 1.75)

< 0.01

Dementia

2.04

(1.38, 3.01)

< 0.001

   

Diabetes

1.52

(1.29, 1.79)

< 0.001

1.13

(0.96, 1.34)

0.14

Number of EPS

1.91

(1.60, 2.29)

< 0.001

   

History of EPS

2.37

(1.88, 2.99)

< 0.001

1.35

(0.74, 2.47)

0.33

Parkinsonism

4.29

(1.38, 13.33)

< 0.05

1.43

(0.44, 4.72)

0.55

Bradykinesia

2.48

(1.92, 3.21)

< 0.001

1.44

(0.77, 2.68)

0.25

Tremors

3.93

(1.96, 7.89)

< 0.001

2.12

(0.97, 4.60)

0.06

Myoclonus

4.27

(1.07, 17.11)

< 0.05

2.33

(0.56, 9.7)

0.25

  1. AP antipsychotic, CCI Charlson Comorbidity Index, CI confidence interval, EPS extrapyramidal symptoms, LASSO least absolute shrinkage and selection operator